Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy

✍ Scribed by Stamatis Adamopoulos; John T. Parissis; Michael Georgiadis; Dimitrios Karatzas; John Paraskevaidis; Christos Kroupis; George Karavolias; Katerina Koniavitou; Dimitrios Th. Kremastinos

• Book ID: 117842887
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 156 KB
• Volume: 144
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1067/mhj.2002.124052